Skip to main content
. 2020 Jan 16;11(1):34. doi: 10.1038/s41419-019-2188-7

Fig. 7. DLGAP1-AS1 promotes HCC development and EMT via Wnt/β-catenin pathway activation through CDK8 and LRP6.

Fig. 7

a qRT-PCR detected that CDK8 or LRP6 level in Hep G2 cells with DLGAP1-AS1 knockdown was upregulated by transfection of pcDNA3.1/CDK8 or pcDNA3.1/LRP6. b TOP/FOP flash assay was performed to verify the deactivating effect of DLGAP1-AS1 knockdown on TCF/LEF transcription, which was reactivated by CDK8 or LRP6 overexpression. c The influences of DLGAP1-AS1 knockdown and CDK8 or LRP6 overexpression on β-catenin expression, phosphorylation, and nuclear translocation were evaluated using WB analysis. d WB analysis displayed the protein levels of several typical downstream genes of Wnt/β-catenin pathway, which were downregulated by DLGAP1-AS1 knockdown and then upregulated by transfection of pcDNA3.1/CDK8 or pcDNA3.1/LRP6. e, f CCK-8 assay and wound healing assay showed that the inhibitory effects on cell proliferation and migration of DLGAP1-AS1 knockdown were attenuated by overexpression of CDK8 and LRP6, as well as by treatment with CHIR99021. g TUNEL assay showed that the promotional effect on cell apoptosis of DLGAP1-AS1 knockdown was attenuated by CDK8, LRP6 or CHIR99021. h, i The influences of CDK8 and LRP6 overexpression and CHIR99021 treatment on EMT-related factors in Hep G2 cells with DLGAP1-AS1 knockdown were respectively analyzed using qRT-PCR and WB. All data are presented as the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01.